Last edition
News about "Spektus Pharma"
Lupin Limited partners with Spektus Pharma to commercialize DeslaFlex in Canada
Lupin Limited has signed a licence and supply agreement with Spektus Pharma to commercialize DeslaFlex, a novel antidepressant, in Canada.
Spektus Pharma | 16/02/2026 | By Darshana | 103
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members